Drug intelligence / Profile preview

3-acetylpyridine adenine dinucleotide

Development stage
Unknown
Modality
Small Molecules
01

Overview

**3-Acetylpyridine adenine dinucleotide (APAD)** is a synthetic analogue of nicotinamide adenine dinucleotide (NAD). It consists of ribosylnicotinamide 5'-diphosphate coupled to adenosine 5'-phosphate by a pyrophosphate linkage, with the nicotinamide moiety replaced by a 3-acetylpyridine group. Like NAD, it acts as an electron carrier in enzymatic redox reactions and can be alternately oxidized and reduced. APAD is widely used as an experimental coenzyme in biochemical research, particularly for studying dehydrogenase enzyme mechanisms and kinetics. It serves as a substrate or inhibitor for various dehydrogenases, including those involved in bacterial and mammalian metabolism[1][2][5][7]. Its altered structure compared to NAD affects its binding properties and suitability as a substrate for certain enzymes[7].

Other names
3-acetyl-NADbeta-3-acetylpyridine adenine dinucleotidebeta3-acetylpyridine adenine dinucleotidebeta 3-acetylpyridine adenine dinucleotideMFCD00078882MFCD-00078882MFCD 00078882CHEBI:166857HY-131485AHY131485AHY 131485ANA30683NA-30683NA 30683
02

Targets

ND1 (Mitochondrial electron transport chain complex I)AKR1B1 (Aldose Reductase)LDH (L-lactate dehydrogenase A chain)

Beyond the preview

Go deeper on 3-acetylpyridine adenine dinucleotide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-acetylpyridine adenine dinucleotide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call